Refine by
Applications
- microbiota for Clinical Studies
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- Actionable Molecular Diagnostic System for Physicians
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Remote Patient Monitoring Solution for Remote Patient Monitoring
- Remote Patient Monitoring Solution for Revenue Cycle Management
- Remote Patient Monitoring Solution for EHR Integration
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
- Liposomes - Hollow Nanospheres for Gene Therapy
- Liposomes - Hollow Nanospheres for Cancer Therapy
- Liposomes - Hollow Nanospheres for Ocular Drug Delivery
- Liposomes - Hollow Nanospheres for Brain Drug Delivery
- Liposomes - Hollow Nanospheres for Vaccines
- Liposomes - Hollow Nanospheres for Immunomodulating Response
- Liposomes - Hollow Nanospheres for Tissue Engineering
- Exosomes - Extracellular Vesicles for Validation and Quality Control
- Exosomes - Extracellular Vesicles for Cancer Treatment
- Exosomes - Extracellular Vesicles for Immunomodulating Response
- Exosomes - Extracellular Vesicles for Molecular Therapy
- Exosomes - Extracellular Vesicles for Brain Drug Delivery
- Exosomes - Extracellular Vesicles for Ocular Drug Delivery
Tumor Treatment Equipment & Supplies
456 equipment items found
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOTATE theranostic radiopharmaceutical kit is an innovative solution formulated as a single vial for the effective treatment of neuroendocrine tumors. It utilizes the Lu-177 radioisotope, enabling the radiopharmaceutical to selectively target neuroendocrine tumor cells, facilitating their complete destruction. This procedure not only ...
Premium
Manufactured by:Vobis LLC based inEaston, PENNSYLVANIA (USA)
Liposomal encapsulation experience particularly specific to lipid-based nanoparticles with encapsulation of variety of payloads including small molecules and nucleic acids (plasmid DNA, siRNA and ASO). We have developed proprietary lipid based nano technologies that have potential benefits in different therapeutic areas including targeted cancer therapy, DNA Vaccination and liver diseases. Here ...
Manufactured by:icotec ag based inAltstätten, SWITZERLAND
The visibility you need. The support you can trust. The postoperative assessment and adjuvant radiation therapy during tumor treatment are no longer limited by metallic implants. The icotec Anterior Cervical Plate System made of BlackArmor® Carbon/PEEK offers translucency, strong and stable fixation that withstands the mechanical demands and stresses of ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Rolling Shield is a mobile rolling shield available in lead equivalency up to 1’’ Pb.Eq. and is being used in several Theranostics suites and radiotherapies such as Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
ClearView Vial Shield can be used for Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan or 177Lu-PSMA-617) for the treatment of prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Infusion Pump Shield fits most infusion pumps such as Grasbey, Medifusion, Moog Curlin, etc. is being used in Theranostics centers for infusion of radiopharmaceuticals such as Lutathera, Azedra, AdreView, Megatope, HICON™. The ClearView Infusion Pump Shield works for infusion treatments from Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) ...
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
Primary aim is in assessing procoagulant states associated with cancer and cancer therapies, to inform physician’s decision making on initiating, pursuing or stopping anticoagulant prophylaxis in cancer patient. ...
by:Ionpath, Inc. based inMenlo Park, CALIFORNIA (USA)
Background: The cytoskeleton is composed of microfilaments, intermediate filaments, and microtubules. β-tubulin, together with α-tubulin, forms heterodimers that serve as the building blocks for microtubules. The structure of microtubules is dynamically regulated in processes related to cell movement, cytoplasmic transport, and chromosome alignment during meiosis/mitosis. ...
by:Edinburgh Molecular Imaging based inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and ...
Manufactured by:Curasight based inKøbenhavn N, DENMARK
Curasight has developed a novel and innovative Theranostics platform for improved cancer diagnose and treatment. The combination of using targeted radionuclide therapy to treat cancer, and a non-invasive PET imaging for diagnosing and monitoring, is known as Theranostics (Therapy + Diagnostics = Theranostics). Curasight’s solution combines the technologies uTREAT® (targeted radionuclide ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus®PLUS is a unique proton therapy solution for leading cancer centers striving to meet a large and growing patient base's treatment needs while further advancing your clinical reputation in cancer care. Its cutting-edge features can be configured into a tailored solution to meet your research, clinical, and business objectives. Proteus®PLUS is inspired by clinical excellence with ...
by:Edinburgh Molecular Imaging based inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and ...
Manufactured by:Bioprojet based inParis, FRANCE
Oral follow-up treatment of injectable therapy for malignant hypercalcaemia, Palliative treatment of osteolysis of malignant origin with or without hypercalcaemia, in conjunction with specific cancer treatment, In the event of hypercalcaemia, the treatment must be associated with optimal rehydration. ...
Manufactured by:Shengkang Fine Chemical Co., Ltd based inHong Kong, CHINA
Name Erlotinib. Molecular Formula C22H23N3O4. Molecular Weight 393.44. CAS Registry Number 183321-74-6. Application Treatment of pancreatic cancer. ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. Corresponding assets ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
XR-18 is a research effort based on the XR-17 technology platform intended to provide enhanced properties that improve clinical formulations and applications of active pharmaceutical ingredients (APIs) for cancer treatment. This effort has recently generated promising data including: Addition of components to existing XR-17 formulation improving certain properties. Synthesis of novel excipients ...
Manufactured by:.decimal based inSanford, FLORIDA (USA)
Grid radiation therapy, using the megavoltage X-ray beam, has been proven to be an effective method for the management of large and bulky malignant tumors. This treatment modality is also known as Spatially Fractionated Radiation Therapy (SFRT). In this treatment technique, a grid block converted the open radiation field into a series of pencil ...
Manufactured by:BridgeBio Pharma, Inc. based inPalo Alto, CALIFORNIA (USA)
Infigratinib is an orally administered, ATP-competitive, FGFR1-3 tyrosine kinase inhibitor in development for the treatment of FGFR-driven cancers. Multiple Phase 3 clinical trials are currently enrolling; please explore www.clinicaltrials.gov for more information. TRUSELTIQ™ (infigratinib) obtained accelerated approval by FDA, was conditionally approved by Health Canada and received ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
CX-072 is a wholly owned PD-L1-targeting Probody therapeutic for the treatment of cancer. Initial clinical data presented at the ASCO and ESMO 2018 Annual Meetings showed that CX-072 demonstrated tolerability and anti-tumor activity, while reducing activation of the immune system outside the tumor. Initial clinical translation data presented at ...
Manufactured by:AJ Vaccines A/S based inKøbenhavn, DENMARK
VesiCulture (BCG Culture) For the treatment of Bladder ...